SCAND2P and prostate adenocarcinoma: SCAND2 and MZF1(ZSCAN6) gene expression was lower in prostate adenocarcinoma (PRAD), breast invasive carcinoma (BRCA), colon adenocarcinoma (COAD), rectum adenocarcinoma (READ), skin cutaneous melanoma (SKCM), testicular germ cell tumors (TGCT) and uterine carcinosarcoma (UCS), while HSP90AA1 and HSP90AB1 gene expression was higher in these cancer types compared with paired normal tissues (Figure 7 and Figure S5).